Registration and Treatment of Pain During Eye Examination of Prematurity

This study is currently recruiting participants.
Verified April 2013 by St. Olavs Hospital
Sponsor:
Collaborator:
Norwegian University of Science and Technology
Information provided by (Responsible Party):
St. Olavs Hospital
ClinicalTrials.gov Identifier:
NCT01552993
First received: March 2, 2012
Last updated: April 11, 2013
Last verified: April 2013

March 2, 2012
April 11, 2013
March 2012
December 2015   (final data collection date for primary outcome measure)
pain [ Time Frame: 5 minutes ] [ Designated as safety issue: No ]
Premature Infant Pain Profile (PIPP): score range 0-21. Used independently by 2 experienced observers
Same as current
Complete list of historical versions of study NCT01552993 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Registration and Treatment of Pain During Eye Examination of Prematurity
Registration and Treatment of Pain During Eye Examination of Prematurity

The aim of this study is to see if paracetamol has a pain-relieving effect during eye examination in premature infants.

Retinopathy of prematurity (ROP) is a feared complication of premature birth. If discovered in time, the disease can be treated, and impaired vision or blindness can be reduced. Premature infants are therefore examined regularly after birth. However, the examination is painful and stressful for the infant. Painful experiences might lead to a pathological stress response later in life and should therefore be prevented.

This is a double blinded, controlled and randomized study where the infants are examined and assessed either with or without the use of paracetamol.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
  • Infant, Premature
  • Retinopathy
  • Drug: paracetamol
    Paracetamol mixture 20 mg/kg + pacifier and glucose
    Other Name: Paracetamol
  • Drug: sucrose
    pacifier and sucrose
  • Experimental: paracetamol
    Paracetamol mixture 20 mg/kg + pacifier and sucrose
    Intervention: Drug: paracetamol
  • Placebo Comparator: placebo
    pacifier and sucrose only
    Intervention: Drug: sucrose
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
70
December 2015
December 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Infants < 32 weeks of gestational age (< 31+6 weeks)

Exclusion Criteria:

  • Infants with ongoing analgesic treatment
Both
31 Weeks to 37 Weeks
No
Contact: Hakon Bergseng, PhD +47 95088255 hakon.bergseng@stolav.no
Contact: Laila Kristoffersen laila.kristoffersen@stolav.no
Norway
 
NCT01552993
HB2012-02
No
St. Olavs Hospital
St. Olavs Hospital
Norwegian University of Science and Technology
Principal Investigator: Hakon Bergseng, PhD St.Olavs University Hospital
St. Olavs Hospital
April 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP